Viewing Study NCT06653543



Ignite Creation Date: 2024-10-26 @ 3:43 PM
Last Modification Date: 2024-10-26 @ 3:43 PM
Study NCT ID: NCT06653543
Status: RECRUITING
Last Update Posted: None
First Post: 2024-09-01

Brief Title: Effect of Mulligan on Cervical Radiculopathy
Sponsor: None
Organization: None

Study Overview

Official Title: Effect of Mulligan Mobilization with Arm Movement on Nerve Conduction Velocity in Patients with Unilateral Cervical Radiculopathy
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to investigate the effect of Mulligan mobilization with arm movement on nerve conduction velocity in patients with unilateral cervical radiculopathy The main questions it aims to answer are

1 Is there a statistical significant effect of mobilization with arm movement on NCV velocity in treatment of cervical radiculopathy
2 Is there a statistical significant effect of mobilization with arm movement on pain level in treatment of cervical radiculopathy
3 Is there a statistical significant effect of mobilization with arm movement on cervical ROM in treatment of cervical radiculopathy
4 Is there a statistical significant effect of mobilization with arm movement on neck disability level in treatment of cervical radiculopathy

The course of treatment involves 6 sessions over the course of 3 weeks participants will be divided into 2 groups Control group recieves only Conventional treatment Experimental group recieves Conventional treatment and Mulligan mobilization with arm movement
Detailed Description: the aim of our study is to examine the effect of Mulligan mobilization with arm movement on cervical radiculopathy using nerve conduction studies in addition to the original measures of previous studies pain level cervical ROM and neck disability scale

Delimitations

Inclusion Criteria

Individuals will be enrolled into the study if they are

diagnosed with cervical radiculopathy
Age group between 20-60 years
Unilateral radiating pain through the course of median nerve
Subject having positive upper limb tension test ULTT 1
either gender male and female
Subjects who can understand the instructions and are willing to participate in the study

Exclusion Criteria

History of trauma dislocation and subluxation of upper extremity
Rheumatoid Arthritis
Malignancy
Spinal canal stenosis
Cervical instabilitySpondylolisthesis
VBI Vertebral-Basillar Insufficiency
Referred pain in patients with cardiac ischemia
Cervical or thoracic spine surgeries
systemic causes like diabetic neuropathy
recent fracture or surgery in and around the shoulder
carpal tunnel syndrome
thoracic outlet syndrome

Outcome measure would include

A The primary outcome measure will be NCV velocity for the median nerve latency amplitude Duration F-wave and nerve conduction velocity of motor nerve action potentials and sensory nerve action potentials SNAPs

B Secondary outcome measures will include

Pain intensity assessed using the Visual Analog Scale VAS
Functional disability evaluated using the Neck Disability Index NDI
Cervical range of motion measured using a CROM goniometer to assess flexion extension lateral flexion and rotation
The course of treatment involves 6 sessions over the course of 3 weeks
pre-treatment for both groups

1 affected nerve conduction velocity will be measured using nerve conduction study
2 neck disability level will be measured using neck disability index
3 cervical ROM measurement will be taken in all directions using CROM goniometer
4 pain will be assessed using Visual analog scale

participants will be divided into 2 groups

Group A- Control group

During each session only Conventional treatment will be provided includes hot pack for 10 minutes active ranges of motion AROMs with 3 sets of 10 repetitions and isometrics for each movement repeated 20 times with the hold of 6 to 10 seconds in each repetition

Group B- Experimental group- Mulligan mobilization group

During each session

1 Conventional treatment will be provided
2 Mulligan mobilization will be applied in the form of sustained passive accessory joint mobilization to a specific spinal vertebra level while simultaneously guiding the patient through an active pain-free movement pattern involving the affected limb
Patient position Sitting upright on chair
Therapist position Standing behind the patient
Hand placement Approach the desired level of spinous process from medial aspect of the thumb of one hand which may be reinforced by the index finger of the other hand
Mobilization Pure transverse glide is performed from affected to unaffected side While the glide is sustained patient performs the offending movements flexionabductionhorizontal adductionhorizontal abduction

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None